Skip to main content

NatWest Group plc

Position in GILD — Gilead Sciences, Inc.

CIK 844150 EDINBURGH, SCOTLAND, X0

Position in GILD

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$6,251,934
-$40,342 QoQ
Shares Held
49,485
+9.6% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.14%
of 13F equity value
Holder Rank
#530
of 2,266 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

NatWest Group plc holds $63,512,390 across 5 Drug Manufacturers - General names. GILD ranks #3 (9.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 GILD
Gilead Sciences, Inc.
This page
49,485 $6,251,934

All Filings in GILD

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,251,934 49,485
2026-03-31 $6,292,276 45,148
2025-12-31 $5,396,263 43,965
2025-09-30 $9,829,605 88,555
2025-06-30 $13,688,674 123,466
2025-03-31 $13,501,800 120,498
2024-12-31 $6,807,853 73,702
2023-03-31 $303,670 3,660
2022-12-31 $381,774 4,447
2022-09-30 $358,171 5,806
2022-06-30 $358,868 5,806
2022-03-31 $553,241 9,306
2021-12-31 $675,708 9,306
2021-09-30 $650,023 9,306
2021-06-30 $2,327,674 33,803
2021-03-31 $2,166,590 33,523
2020-12-31 $1,945,243 33,389
2020-09-30 $2,678,813 42,393
2020-06-30 $2,840,777 36,922
2020-03-31 $2,459,678 32,901